ARM Arm Holdings plc : Bullish and Bearish Analyst Opinions

Watching AI chip stocks for correction.

The author is long ARM due to an anticipated ramp in AI CPU demand.

When asked about Qualcomm (QCOM), Cramer replies, "We don't want to... why don't you just go buy ARM? I mean, I think ARM is much better than Qualcomm." He directly contrasts the two, stating ARM is "making a series of good steps" while Qualcomm is making missteps. ARM is presented as the superior investment choice in the semiconductor/IP space. Execution risk; competition in chip architecture.

Samsung's shift from Arm to RISC-V for a key component threatens Arm's licensing revenue and signals a potential trend of major customers seeking design flexibility and cost reduction, creating headwinds for ARM.

UBS highlights growth opportunities for Nvidia, Marvell, and ARM in the AI infrastructure market while noting increased competition for Broadcom.

Cramer discussed ARM Holdings' new AI chip for data centers, which targets $15 billion in sales within five years, with Meta as a key customer, marking a shift from IP licensing to chip sales. The company's AGI CPU offers twice the performance at the same power as x86 competitors, positioning it to capture value in the booming AI infrastructure market. ARM's strategic transition and technological edge support long-term growth potential. Execution challenges, competition from Intel and AMD, or a slowdown in AI investment could hinder growth.

The Cambridge deep tech ecosystem is highlighted as a highly undervalued hub with significant growth potential across various sectors.

Arm's strong long-term guidance sets a positive precedent for Qualcomm's upcoming analyst day.

Arm's strategic pivot is projected to drive significant long-term revenue and profit growth despite potential margin compression.

Arm unveiled its first in-house CPU, shifting business model; Raymond James upgraded to Outperform with $166 PT (~23% upside). This move into fabless chip design is expected to boost operating profit and create a new revenue stream on top of licensing, timed with the AI data center CPU demand boom. The strategic shift is seen as a positive catalyst that may not be fully priced in, offering potential upside. Execution risk in new business line; increased competition with INTC and AMD; potential for market to have already priced in the news.

ARM Holdings soared 16% after announcing it will begin selling its own chips (AGI CPU), with Meta as its first major customer. The company expects the new chip business to generate $15 billion in annual revenue within five years, signaling a significant new growth vector. The market reaction and substantial revenue target indicate strong bullish conviction in the strategic shift. Execution risk in ramping up a new hardware business and competition in the chip design space.

ARM plans to design and sell its own chips, aiming to reach $15 billion in annual sales within five years, moving beyond licensing to capture more value. This strategic pivot allows ARM to participate directly in the lucrative AI data center market, where demand is surging, potentially boosting revenue despite lower margins. LONG due to significant growth potential in AI and data centers, with ARM leveraging its low-power chip expertise. Execution challenges in chip manufacturing and increased competition from existing players like Intel and AMD.

Reported that "ARM shares rising 13% in the premarket as the company moves to sell its own chips... It is a big pivot for this company as it takes aim at the fast-growing data center market tied to AI." The company is shifting from a pure licensing model to a higher-margin, direct sales model targeting the high-growth AI data center market, with an expected $15bn annual revenue from this new business within five years. This is LONG because the strategic pivot directly captures the immense and sustained investment cycle in AI infrastructure, representing a major new growth vector. Execution risk in manufacturing and competition from established chipmakers.

The author is taking a bullish stance on ARM based on the company's strategic expansion into the artificial intelligence chip market.

The author expresses optimism for ARM's potential to reach new highs and considers NVDA a strong buy.

ARM and Meta partner to develop a new AGI CPU for AI data centers.

Rising CPU prices and extended lead times signal strong demand and supply constraints for semiconductor manufacturers.

ARM is well-positioned for growth in the GAI CPU market as it gains momentum over x86 architecture.

Arm is transitioning its business model with the launch of its AGI CPU and a strong five-year revenue target.

Neil Campling states Arm's move to manufacture its own chips is "transformational," representing a potential 100-fold increase in revenue per chip compared to licensing. By moving down the value chain from IP licensor to chip designer/seller, Arm captures a much larger share of the final chip's value, directly benefiting from the massive AI-driven compute capex cycle. This is a fundamental, positive reinvention of the business model with a clear path to significantly higher revenue and profit. Execution risk in manufacturing and competition from established players like AMD and Intel.

The author is highly bullish on ARM, comparing it to past major semiconductor winners and citing anticipated revenue expansion from its AI CPUs as the primary catalyst.

ARM's strategic pivot to manufacturing their own AI CPUs will drive massive revenue growth, overriding previous bearish concerns about RISC-V cannibalization.

The author is long ARM, betting that the shift toward lightweight LLMs and AI inference will allow ARM's CPUs to cannibalize Nvidia's market share and drive massive revenue multiples.

Arm will begin selling its own chips for the first time (Arm AGI CPU), with Meta as the lead partner. The CEO expects this new business to generate $15 billion in annual sales within five years, contributing to revenue this year. The "agentic AI" trend drives massive compute demand, not just for token generation but for orchestration and scheduling, which CPUs handle. Arm is at the heart of AI compute workloads, and this product directly monetizes that position with a material new revenue stream. LONG due to the creation of a significant, high-growth revenue stream that leverages Arm's core AI positioning. SoftBank, as the majority stakeholder, is a direct beneficiary of Arm's success. Failure to achieve design wins or ship volumes at the anticipated scale; competition from other CPU architectures.

ARM shifts strategy by unveiling its first in-house AGI data center CPU.

ARM warrants an upward valuation re-rating driven by significant expected revenue growth from a new product line.

The market is significantly underpricing the fundamental impact of ARM's new AGI CPU, which is projected to add $15B in annual revenue and effectively multiply the company's current top line.

Bearish on ARM due to the rising competitive threat and market share potential of the open-source RISC-V architecture.

ARM's shift to silicon expands its revenue potential but threatens margins and increases competition for Intel in the server CPU market.

ARM is a potential short due to a combination of potential selling pressure from its largest holder and a weak business model characterized by high R&D costs and low royalties.